Anixa Biosciences Inc Quarterly Return On Equity in % from Q2 2018 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Anixa Biosciences Inc quarterly/annual Return On Equity history and growth rate from Q2 2018 to Q2 2024.
  • Anixa Biosciences Inc Return On Equity for the quarter ending July 31, 2024 was -54.8 %, a 36.5% decline year-over-year.
  • Anixa Biosciences Inc annual Return On Equity for 2023 was -38.9 %, a 11.4% increase from 2022.
  • Anixa Biosciences Inc annual Return On Equity for 2022 was -43.9 %, a 2.4% decline from 2021.
  • Anixa Biosciences Inc annual Return On Equity for 2021 was -42.9 %, a 71.9% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -54.8 -14.7 -36.5% May 1, 2024 Jul 31, 2024
Q1 2024 -49.3 -10.6 -27.3% Feb 1, 2024 Apr 30, 2024
Q4 2023 -44.1 -2.91 -7.07% Nov 1, 2023 Jan 31, 2024
Q3 2023 -38.9 +5 +11.4% Aug 1, 2023 Oct 31, 2023
Q2 2023 -40.1 +3.24 +7.47% May 1, 2023 Jul 31, 2023
Q1 2023 -38.7 +7.78 +16.7% Feb 1, 2023 Apr 30, 2023
Q4 2022 -41.2 +0.19 +0.46% Nov 1, 2022 Jan 31, 2023
Q3 2022 -43.9 -1.03 -2.4% Aug 1, 2022 Oct 31, 2022
Q2 2022 -43.4 +4.01 +8.46% May 1, 2022 Jul 31, 2022
Q1 2022 -46.5 +9.98 +17.7% Feb 1, 2022 Apr 30, 2022
Q4 2021 -41.4 +71 +63.2% Nov 1, 2021 Jan 31, 2022
Q3 2021 -42.9 +110 +71.9% Aug 1, 2021 Oct 31, 2021
Q2 2021 -47.4 May 1, 2021 Jul 31, 2021
Q1 2021 -56.5 Feb 1, 2021 Apr 30, 2021
Q4 2020 -112 Nov 1, 2020 Jan 31, 2021
Q3 2020 -153 Aug 1, 2020 Oct 31, 2020
Q3 2018 -236 Aug 1, 2018 Oct 31, 2018
Q2 2018 -128 May 1, 2018 Jul 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.